Cytori Selected By Fraunhofer Society To Develop New Stem And Regenerative Cell-Based Treatments For Stroke
Cytori Therapeutics (NASDAQ:CYTX) and the Fraunhofer Institute for Cell Therapy and Immunology (IZI) formed collaboration to develop adipose-derived stem and regenerative cell-based treatments for ischemic stroke. The Fraunhofer Society will commit $425,000 over two years in support to Cytori’s already planned research and development. The goal of the collaboration is to advance adipose-derived stem and regenerative cells into clinical trials for ischemic stroke.
More: continued here